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Abstract
Background: Excess body weight, physical activity, smoking, alcohol consumption and certain dietary factors are
individually related to colorectal cancer (CRC) risk; however, little is known about their joint effects. The aim of this
study was to develop a healthy lifestyle index (HLI) composed of five potentially modifiable lifestyle factors –
healthy weight, physical activity, non-smoking, limited alcohol consumption and a healthy diet, and to explore the
association of this index with CRC incidence using data collected within the European Prospective Investigation into
Cancer and Nutrition (EPIC) cohort.
Methods: In the EPIC cohort, a total of 347,237 men and women, 25- to 70-years old, provided dietary and lifestyle
information at study baseline (1992 to 2000). Over a median follow-up time of 12 years, 3,759 incident CRC cases
were identified. The association between a HLI and CRC risk was evaluated using Cox proportional hazards
regression models and population attributable risks (PARs) have been calculated.
Results: After accounting for study centre, age, sex and education, compared with 0 or 1 healthy lifestyle factors,
the hazard ratio (HR) for CRC was 0.87 (95% confidence interval (CI): 0.44 to 0.77) for two factors, 0.79 (95% CI: 0.70
to 0.89) for three factors, 0.66 (95% CI: 0.58 to 0.75) for four factors and 0.63 (95% CI: 0.54 to 0.74) for five factors;
P-trend <0.0001. The associations were present for both colon and rectal cancers, HRs, 0.61 (95% CI: 0.50 to 0.74; P
for trend <0.0001) for colon cancer and 0.68 (95% CI: 0.53 to 0.88; P-trend <0.0001) for rectal cancer, respectively
(P-difference by cancer sub-site = 0.10). Overall, 16% of the new CRC cases (22% in men and 11% in women) were
attributable to not adhering to a combination of all five healthy lifestyle behaviours included in the index.
Conclusions: Combined lifestyle factors are associated with a lower incidence of CRC in European populations
characterized by western lifestyles. Prevention strategies considering complex targeting of multiple lifestyle factors
may provide practical means for improved CRC prevention.
Keywords: lifestyle factors, combined impact, population attributable risks, colorectal cancer, European Prospective
Investigation into Cancer and Nutrition (EPIC)
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Colorectal cancer (CRC) is the third most common can-
cer in men (746,000 cases per year, 10.0% of the total
cancer incidence) and the second in women (614,000
cases per year, 9.2% of the total cancer incidence) world-
wide [1]. There is a wide geographical variation in CRC
incidence rates across the world with almost 55% of the
cases occurring in more developed regions [1]. The par-
allel between the cancer frequency rates and the level of
‘westernisation’ points to an important role of lifestyle
factors in the etiology of CRC [2-13]. In support of this
hypothesis, the World Cancer Research Fund/American
Institute for Cancer Research (WCRF/AICR) expert pa-
nel acknowledged that high physical activity and high
intakes of dietary fibre, fish, nuts, dairy products, and
fruits and vegetables are associated with a lower CRC
risk, whereas high body mass index (BMI) and waist cir-
cumference, smoking, alcohol consumption, and red and
processed meat intakes are related to a higher CRC risk
[14-16]. While individual roles of these lifestyle factors
have been extensively investigated, little is known about
their joint effects. Most epidemiological studies explored
individual health behaviours by treating other lifestyle
factors as covariates in statistical models; however, in
real life it is uncommon that people practice isolated be-
haviours. A multidimensional lifestyle approach would
be more informative for exploring disease etiology, as
well as for translating epidemiological findings into mea-
ningful prevention strategies. Furthermore, estimation of
health impact measures, such as population attributable
risks (PARs), may provide better means for public health
decision making, because PARs address what proportion
of disease risk may be prevented over a specified time
interval if a risk factor (or a combination of risk factors)
is absent in a given population [17]. In addition, differ-
ences between colon and rectal anatomical cancer sub-
types and sex have been previously shown to exist for
associations with several lifestyle factors, such as excess
body weight, waist circumference and physical inactivity
[18-20]; however, it is not clear whether such differences
may be valid also for combinations of factors. Finally,
varying combinations of risk factors differentially con-
tribute to diabetes, cardiovascular diseases and cancer
overall [21]; therefore, it may be important to investigate
specific lifestyle patterns in relation to CRC risk. To ad-
dress these aspects, we aimed to develop a healthy life-
style index (HLI) composed of five potentially modifiable
lifestyle factors – healthy weight, physical activity, non-
smoking, limited alcohol consumption and a healthy diet
– and to explore the association of this index with CRC
incidence using data collected within the European Pro-
spective Investigation into Cancer and Nutrition (EPIC)
cohort. Furthermore, we aimed to evaluate the com-
bined impact of these lifestyle factors in terms of PARs
overall and according to colon and rectal cancer ana-
tomical sub-site and by sex.
Methods
Study design and population
A total of 521,330 men and women, 25- to 70-years old,
were recruited between 1 January 1992 and 31 December
2000 from 23 centres in 10 European countries: Denmark,
France, Germany, Greece, Italy, the Netherlands, Norway,
Spain, Sweden and the United Kingdom. Approval for the
EPIC study was obtained from the ethical review boards
of the International Agency for Research on Cancer and
from all local institutions where subjects had been re-
cruited for the EPIC study [see Additional file 1: Table S1].
Written informed consent was obtained from all partici-
pants before joining the EPIC study. Details of the recruit-
ment and study design have been published elsewhere
[22]. We excluded participants with missing data on diet-
ary factors (n=6,193), waist circumference measurements
(n=109,302), smoking history (11,746), physical activity
(n=69,393), underweight participants (BMI <18; n =
95,381) and participants with prevalent diabetes re-
ported at study baseline (n =13,049). Due to missing
data on waist circumference measurements, participants
from Norway (n=35,890) were excluded from the ana-
lyses. Consequently, the study population for the current
analyses was comprised of 3,759 CRC cases (2,369 colon
cancers and 1,390 rectal cancers) and 343,478 non-cases.
Case ascertainment
Cancer cases were identified through population cancer
registries in Denmark, Italy, the Netherlands, Spain,
Sweden and the United Kingdom. In France, Germany
and Greece, a combination of methods was used includ-
ing health insurance records, cancer pathology registries
and active follow-up of study participants and their next
of kin. Follow-up began at the date of enrolment and
ended at the date of diagnosis of cancer, death or last
complete follow-up. The last update of endpoint informa-
tion was done up to 31 September 2010. Cancer incidence
data were coded according to the 10th revision of the
International Statistical Classification of Diseases, Injuries
and Causes of Death [23] and the second revision of the
International Classification of Diseases for Oncology [24].
Only the first primary neoplasm was included in the ana-
lysis; non-melanoma skin cancer was excluded.
Assessment of lifestyle factors
At baseline, participants filled out extensive medical, diet-
ary and lifestyle questionnaires, including questions on al-
cohol use, smoking status, physical activity, education and
previous illnesses. Body weight, height and waist circum-
ference were measured in all centres except for EPIC-
Oxford (health-conscious population) and France where
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Usual food intakes were measured by using country-
specific validated dietary questionnaires, and individual
nutrient intakes were derived from foods included in the
dietary questionnaires through the standardised EPIC
Nutrient Database [25]. All dietary variables used in the
present study were calibrated by using an additive calibra-
tion method as previously described [26].
HLI definition
We generated the HLI based on a priori knowledge of
the CRC risk factors [2-13] and available national and
international public health recommendations (that is,
WCRF/AICR (2007)) [15,16]. We used a binary score for
each factor in order to allow easy translation of findings
into a prevention practice (Table 1). Participants were
assigned one point for each of the following behaviours
assessed at study baseline: healthy weight (BMI <25 [27]
or waist circumference <80 cm for women and <94 cm
for men [28]); not smoking or former smoking, high
physical activity [13], adherent to alcohol consumption
recommendations of the WCRF/AICR (2007) [16] and
having a healthy diet. Healthy diet was evaluated based
on a dietary quality index including eight dietary factors
(fruits, vegetables, red and processed meat, fibre, fish,
nuts, garlic and yogurt), which were previously shown
to be related to CRC [see Additional file 2: Table S2]. Fi-
nally, the HLI was constructed by summing the binary
score for each of the five lifestyle factors which ranged
from 0 (least healthy) to 5 (most healthy) points.
Statistical analysis
In descriptive analyses, we estimated the prevalence of
each individual lifestyle factor included in the HLI and
examined the baseline characteristics of the study partic-
ipants according to an increasing HLI score. We next
evaluated the association of the lifestyle factors modeled
individually and in combination - as an index variable
(HLI) - with risk of CRC. We used multivariable Cox pro-
portional hazards models to calculate hazard ratios and
95% confidence intervals (CIs). Age (continuous) was used
as the primary time-dependent variable in all models, with
entry time defined as the subject’s age at recruitment
(years) and exit time as the age at diagnosis, death or
Table 1 Description and prevalences of the factors comprising the Healthy Lifestyle Index (HLI), the EPIC Cohort (1992
to 2010)
Lifestyle factor Index
points
Description Prevalence in the EPIC study
population (%)
Men Women Overall
Overweight and obesity
a 0 Overweight or obese: BMI ≥25 kg/m
2 or waist circumference ≥94 cm for
men and ≥80 cm for women
1 Healthy weight: BMI 18 to 25 kg/m
2 or waist circumference <94 for men cm
and <80 for women
52.2 62.1 58.6
Physical activity
b 0 Low and very low physical activity: sedentary or standing occupation and
recreational METs ≤57 for men and METs ≤82 for women
1 High and very high physical activity: manual or heavy manual occupation
and recreational METs >57 for men and METs >82 for women
50.3 52.6 51.7
Smoking 0 Smoking: current smokers
1 Non-smoking: never or former smokers 69.1 79.8 76.1
Alcohol consumption 0 Heavy alcohol consumption: not adherent to alcohol consumption
recommendations of WCRF/AICR (2007) [15] for two standard drinks a day
(>24 g/day) for men and one standard drink a day (>12 g/day) for women
1 Limited alcohol consumption: adherent to alcohol consumption
recommendations of WCRF/AICR (2007) [15,16] for two standard drinks a day
(≤24 g/day) for men and one standard drink a day (≤12 g/day) for women
66.0 75.9 72.4
Diet quality
c 0 Unhealthy diet quality: 0 to 4 points of the diet index of colorectal cancer
related foods
1 Healthy diet quality: 5 to 8 points of the diet index of colorectal cancer
related foods
60.9 59.6 60.1
aBased on the World Health Organisation’s standard cutoff point for overweight [27] or waist circumference <80 cm for women and <94 cm for men according to
the European Group for the Study of Insulin Resistance (EGIR) recommendations for European populations [28].
bA MET is defined as the ratio of work metabolic
rate to a standard metabolic rate of 1.0 (4.184 kJ) kg
−1 h
−1; 1 MET is considered a resting metabolic rate obtained during quiet sitting. The MET values assigned to
the non-occupational data were 3.0 for walking, 6.0 for cycling, 4.0 for gardening, 6.0 for sports, 4.5 for home repair (do-it-yourself work), 3.0 for housework and
8.0 for stair climbing [13].
cHealthy diet was evaluated based on a dietary quality index including eight dietary factors (fruits, vegetables, red and processed meat,
fibre, fish, nuts, garlic and yogurt), which were previously shown to be related to CRC overall and in the EPIC data [2-8,11,12,38-40] (Additional file 2, Table S2).
BMI, body mass index (calculated as weight in kilograms divided by height in squared metres); EPIC, European Prospective Investigation into Cancer and Nutrition;
METs , metabolic equivalents of energy expenditure (MET)-hours per week per year; WCRF/AICR, World Cancer Research Fund/American Institute for
Cancer Research.
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first. Individual associations of the lifestyle factors with
CRC were evaluated with each lifestyle factor modeled as
a binary variable. The base model was stratified by EPIC
study centre, and adjusted for age at study recruitment,
sex (in the sex combined model) and educational level.
The multivariable model for individual lifestyle factors
was additionally adjusted for the remaining lifestyle fac-
tors. In these analyses, participants with 0 points (least
healthy) were the reference group. To evaluate the associ-
ation of the lifestyle factors in combination, we modeled
the HLI both as an ordinal variable and as a categorical
variable according to six categories (0 to 5 points) with
the least healthy group (0 points) as the reference group.
P-value for the linear trend was calculated using the Wald
test treating the index as a continuous variable. Since nor-
mal body weight may be considered as a consequence of
healthy lifestyle behaviours (that is, high physical activity
and a healthy diet), we performed a subgroup analysis ex-
cluding participants with healthy weights (0 to 4 scores).
In order to test whether individual factors may statistically
explain the association between the combined index and
CRC, we added each of the factors to the multivariable-
adjusted model one at a time. The percent change in the
regression coefficient with adjustment for each individual
lifestyle factor was compared with the multivariable mo-
del. The corresponding 95% CI was calculated based on
Fieller’s theorem [29]. In addition, we examined the multi-
variable risks of CRC according to all possible combina-
tions of lifestyle factors. The five dichotomised healthy
lifestyle factors yielded thirty two combinations and the
hazard ratios (HRs) for each of these combinations were
calculated using participants who had no healthy factors
as the reference group. All analyses were performed separ-
ately for colon and rectal cancer and by sex. Differences
by cancer site were tested by competing risk analyses
using the model of Lunn-McNeil [30], whereas the differ-
ences by sex were tested based on the likelihood ratio test
by generating cross-product terms in multivariable models.
Under the assumption that the associations are causal, we
calculated the percentage of PARs and 95% CIs to estimate
the proportion of CRC cases attributed to each individual
lifestyle factor, as well as to lack of adherence to all of the
five healthy lifestyle factors. For these analyses, we com-
pared participants in the high-risk category with the rest of
the population for each factor and for the index. PARs for
single lifestyle factors were derived from equations by
Miettinen [31] taking the strata specific prevalences of
cases and multivariable-adjusted HRs into consideration.
Attributable risks for factors in combination (PARj)w e r e
determined using an equation by Bruzzi et al. [32]:
PARj ¼ ρj
RRJ‐1
RRj
;
where ρj is the prevalence of individuals not in the
low risk group and RRj is the associated multivariable-
adjusted hazard ratio. Upper and lower CIs of the PARs
were calculated based on the formula by Whittemore
et al.[ 33], as reported in previous analyses [34-36]. We
stratified the analysis according to median age (52.4 years)
and country in order to examine the potential of effect
modification by any of these factors. In addition, we per-
formed sensitivity analysis to account for possible influ-
ence on the associations of family history as an established
risk factor for CRC using available data from the EPIC
centres in France, Spain and the United Kingdom, where
5,309 participants have reported having a family history of
CRC. We also performed analyses comparing participants
with and without missing data on major lifestyle exposure
variables in order to control for potential missing data
bias. Finally, we performed a lag analysis excluding partici-
pants diagnosed with cancer within the first two years of
study follow-up to control for potential influence of sub-
clinical disease on these associations. All statistical ana-
lyses were performed using the Statistical Analysis System
(SAS) (version 9.2), Enterprise Guide User Interface
(version 4.3); SAS Institute, Inc., Cary, NC, USA. All
P values were based on two-sided tests, and P <. 0 5
was considered statistically significant.
Results and discussion
The median follow-up time of the study was 12 years
(5th to 95th centile: 7.0 to 14.5). The total cohort’s me-
dian age was 51.8 ±10.2 years, and 121,116 (35%) of the
participants were men. Among the study population,
203,595 (59%) participants had BMI and waist circum-
ference within the recommended range, 179,787 (52%)
had high physical activity, 264,153 (76%) were non-
smokers (among these, 63% had never smoked and 37%
were former smokers), 251,523 (72%) had alcohol intake
within the recommended limits, and 208,562 (60%) had
a healthy diet as assessed by the dietary quality index
(Table 1). The participants having a higher HLI were
more likely to be women and tended to have a higher
educational level (Table 2). Each healthy lifestyle factor
was associated with a reduction in CRC risk after taking
age, sex, educational status and the remaining lifestyle
factors into account (Table 3). Compared with participants
with no or one healthy lifestyle factors, the multivariable-
adjusted HR for CRC was 0.87 (95% CI: 0.76 to 0.98) for
two factors, 0.79 (95% CI: 0.70 to 0.89) for three factors,
0.66 (95% CI: 0.58 to 0.75) for four factors and 0.63
(95% CI: 0.54 to 0.74) for five factors; P-trend <0.0001
(Figure 1). When evaluated ordinally, each additional
healthy lifestyle factor was associated with a 12% lower
risk of CRC (HR for a one point increase on the index=
0.88; 95% CI: 0.86 to 0.92), 13% lower risk of colon cancer
(HR=0.87; 95% CI=0.83 to 0.90) and 9% lower risk of
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by cancer sub-site=0.10; Table 4). Overall, the associa-
tions between HLI and CRC were stronger in men com-
pared to women (P-interaction=0.03); however, when
stratified by cancer site it became obvious that these dif-
ferences could be mostly observed for rectal cancer but
not for colon cancer (P-interaction=0.0008). Additional
adjustment for each of the individual lifestyle factors did
not materially change the associations of HLI with CRC
[see Additional file 3: Table S3]. However, in analyses by
cancer site and sex, overweight and obesity appeared to
statistically significantly explain the association of HLI
with colon cancer in men by 29% (95% CI: 7% to 62%). In
analysis based on an index that excluded healthy weight,
the associations remained similar (that is, HR for a one
point increase on the index=0.89; 95% CI: 0.87 to 0.92,
for CRC). The estimated PARs of CRC representing
the percentage of the population attributable to non-
adherence to the particular healthy lifestyle behaviour
were 8%, 3%, 4%, 4% and 5% for healthy weight, physical
activity, non-smoking, limited alcohol consumption and a
healthy diet, respectively. Overall 16% of the new CRC
cases (22% in men and 11% in women) were attributable
to not adhering to a combination of all of these five
healthy lifestyle behaviours (Table 5). The results revealed
a cancer-site and sex-specific gradient in estimated PARs
such that 36% of rectal cancer cases in men and 20% of
colon cancer cases in women were attributable to not ad-
hering to all five healthy lifestyle factors, while no signifi-
cant PARs were seen for colon cancer in men and rectal
cancer in women. When we conducted analyses according
to different combinations of two, three and four healthy
lifestylefactors relative to no or one factors, we did not ob-
serve a lower risk for any of the combinations of two
Table 2 Baseline characteristics of participants by Healthy Lifestyle Index (HLI) score, the EPIC cohort (1992 to 2010)
Characteristics Healthy lifestyle index points
0 1 23 45
Participants, number (%) 2,783 (0.8) 20,865 (6.0) 66,110 (19.0) 113,171 (32.6) 106,518 (30.7) 37,790 (10.9)
Colon cancer, number of cases 28 188 526 816 602 209
Rectal cancer, number of cases 12 121 326 459 348 124
Colorectal cancer, number of cases 40 309 852 1275 950 333
Socio-demographic characteristics:
Age, mean, SD 52.7 52.1 52.2 51.9 51.5 50.8
Men,% 58.5 51.0 42.9 34.5 28.3 29.6
University degree,% 21.4 22.8 22.9 23.6 24.1 25.5
Lifestyle factors:
BMI, kg/m
2median 28.1 27.4 26.7 25.6 24.5 23.5
Waist circumference, cm, median
Men 101.0 100.0 98.0 95.0 90.5 87.3
Women 89.0 85.0 83.0 80.0 77.0 73.6
METs recreational and household activity 44.8 54.1 66.5 81.3 98.8 122.8
Never or former smokers,% - 2.0 13.4 33.1 37.0 14.3
Alcohol consumption, grams/day, median
Men 46.0 37.2 25.5 13.8 9.5 7.5
Women 24.2 18.1 11.0 4.5 2.3 1.9
Dietary factors, grams/day, median
Fibre 17.1 18.3 19.6 21.4 24.0 26.3
Fruits 88.4 113.2 146.6 195.1 256.6 287.1
Vegetables 107.3 120.4 136.3 165.6 216.4 245.7
Yoghurt 4.1 8.9 16.2 24.5 40.1 53.6
Nuts 0.66 0.69 0.82 0.82 1.60 2.33
Garlic 6.9 6.8 6.6 7.7 12.6 16.0
Red and processed meat 128.0 119.0 109.5 98.9 85.5 72.7
Fish 17.5 17.5 17.9 19.7 22.8 24.0
BMI, body mass index (calculated as weight in kilograms divided by height in squared meters); EPIC, European Prospective Investigation into Cancer and Nutrition;
METs, metabolic equivalents of energy expenditure (MET)-hours per week per year; SD, standard deviation.
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Colon cancer Rectal cancer Colorectal cancer
Healthy lifestyle factor Index Cases,
number
Model 1
a
HR (95% CI)
Model 2
b
HR (95% CI)
Cases,
number
Model 1
a
HR (95% CI)
Model 2
b
HR (95% CI)
Cases,
number
Model 1
a
HR (95% CI)
Model 2
b
HR (95% CI)
All
Overweight and obesity 0 1,231 1 (Ref.) 1 (Ref.) 671 1 (Ref.) 1 (Ref.) 1,902 1 (Ref.) 1 (Ref.)
1 1,138 0.80 (0.73-0.87) 0.80 (0.74-0.87) 719 0.93 (0.84-1.03) 0.92 (0.82-1.03) 1,857 0.84 (0.79-0.90) 0.84 (0.79-0.90)
Physical activity 0 1,144 1 (Ref.) 1 (Ref.) 648 1 (Ref.) 1 (Ref.) 1,792 1 (Ref.) 1 (Ref.)
1 1,225 0.87 (0.80-0.95) 0.88 (0.81-0.96) 742 1.02 (0.91-1.14) 1.03 (0.92-1.15) 1,967 0.92 (0.86-0.99) 0.94 (0.87-1.00)
Smoking 0 550 1 (Ref.) 1 (Ref.) 378 1 (Ref.) 1 (Ref.) 928 1 (Ref.) 1 (Ref.)
1 1,819 0.90 (0.82-1.00) 0.91 (0.83-1.00) 1,012 0.82 (0.72-0.93) 0.84 (0.74-0.95) 2,831 0.87 (0.81-0.94) 0.88 (0.82-0.96)
Alcohol consumption 0 695 1 (Ref.) 1 (Ref.) 462 1 (Ref.) 1 (Ref.) 1,157 1 (Ref.) 1 (Ref.)
1 1,671 0.91 (0.83-0.99) 0.91 (0.83-1.00) 928 0.79 (0.71-0.89) 0.81 (0.72-0.91) 2,602 0.86 (0.80-0.93) 0.87 (0.81-0.94)
Diet quality 0 1,084 1 (Ref.) 1 (Ref.) 629 1 (Ref.) 1 (Ref.) 1,713 1 (Ref.) 1 (Ref.)
1 1,285 0.86 (0.79-0.94) 0.88 (0.81-0.96) 761 0.87 (0.78-0.98) 0.89 (0.79-1.01) 2,046 0.86 (0.81-0.93) 0.88 (0.83-0.95)
Men
Overweight and obesity 0 602 1 (Ref.) 1 (Ref.) 393 1 (Ref.) 1 (Ref.) 995 1 (Ref.) 1 (Ref.)
1 427 0.73 (0.64-0.83) 0.74 (0.65-0.84) 335 0.89 (0.76-1.03) 0.90 (0.77-1.05) 762 0.79 (0.72-0.87) 0.80 (0.73-0.88)
Physical activity 0 515 1 (Ref.) 1 (Ref.) 360 1 (Ref.) 1 (Ref.) 875 1 (Ref.) 1 (Ref.)
1 514 0.90 (0.79-1.00) 0.91 (0.80-1.03) 368 0.92 (0.79-1.08) 0.93 (0.80-1.09) 882 1.09 (0.99-1.20) 1.08 (0.98-1.19)
Smoking 0 289 1 (Ref.) 1 (Ref.) 223 1 (Ref.) 1 (Ref.) 512 1 (Ref.) 1 (Ref.)
1 740 0.95 (0.82-1.09) 0.96 (0.83-1.10) 505 0.88 (0.75-1.04) 0.92 (0.78-1.08) 1,245 0.92 (0.83-1.02) 0.94 (0.97-1.00)
Alcohol consumption 0 377 1 (Ref.) 1 (Ref.) 287 1 (Ref.) 1 (Ref.) 664 1 (Ref.) 1 (Ref.)
1 652 0.83 (0.73.0.95) 0.85 (0.74-0.97) 441 0.74 (0.63-0.87) 0.76 (0.64-0.89) 1,093 0.79 (0.72-0.88) 0.81 (0.73-0.89)
Diet quality 0 451 1 (Ref.) 1 (Ref.) 342 1 (Ref.) 1 (Ref.) 793 1 (Ref.) 1 (Ref.)
1 578 0.88 (0.76-1.00) 0.89 (0.78-1.02) 386 0.78 (0.67-0.92) 0.80 (0.68-0.94) 964 0.84 (0.75-0.93) 0.85 (0.77-0.95)
Women
Overweight and obesity 0 629 1 (Ref.) 1 (Ref.) 278 1 (Ref.) 1 (Ref.) 907 1 (Ref.) 1 (Ref.)
1 711 0.85 (0.76-0.96) 0.86 (0.77-0.96) 384 0.97 (0.82-1.14) 0.95 (0.81-1.12) 1,095 0.89 (0.81-0.98) 0.89 80.81-0.97)
Physical activity 0 629 1 (Ref.) 1 (Ref.) 288 1 (Ref.) 1 (Ref.) 917 1 (Ref.) 1 (Ref.)
1 711 0.85 (0.75-0.95) 0.86 (0.77-0.97) 374 1.16 (0.98-1.37) 1.17 (0.99-1.38) 1,085 0.94 (0.85-1.04) 0.95 (0.86-1.05)
Smoking 0 261 1 (Ref.) 1 (Ref.) 155 1 (Ref.) 1 (Ref.) 416 1 (Ref.) 1 (Ref.)
1 1,079 0.87 (0.76-1.01) 0.88 (0.77-1.02) 507 0.76 (0.63-0.92) 0.76 (0.63-0.93) 1,586 0.83 (0.74-0.93) 0.84 (0.75-0.94)
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8Table 3 Hazard ratios of colorectal cancer in relation to individual lifestyle factors, the EPIC cohort (1992 to 2010) (Continued)
Alcohol consumption 0 318 1 (Ref.) 1 (Ref.) 175 1 (Ref.) 1 (Ref.) 493 1 (Ref.) 1 (Ref.)
1 1,022 0.99 (0.87-1.13) 0.99 (0.88-1.14) 487 0.90 (0.75-1.07) 0.91 (0.76-1.09) 1,509 0.96 (0.87-1.06) 0.96 (0.87-1.07)
Diet quality 0 633 1 (Ref.) 1 (Ref.) 287 1 (Ref.) 1 (Ref.) 920 1 (Ref.) 1 (Ref.)
1 707 0.84 (0.75-0.95) 0.86 (0.77-0.97) 375 0.98 (0.83-1.17) 1.00 (0.84-1.18) 1,082 0.89 (0.81-0.98) 0.91 (0.82-1.00)
aBase model stratified by EPIC study centre and adjusted for age, sex, education (none, primary school, technical/professional school).
bMultivariable model stratified by EPIC study centre and adjusted for age, sex,
education (none, primary school, technical/professional school, university degree) and after mutual adjustment for other lifestyle factors, including overweight and obesity, physical activity, smoking, alcohol
consumption, and diet quality (binary variables). CI, confidence interval; EPIC, European Prospective Investigation into Cancer and Nutrition; HR, hazard ratio; PAR, population attributable fraction; Ref., reference.
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8factors; whereas the risk of CRC was lower for several
combinations of three healthy lifestyle factors (Figure 2).
Among these, the combination of healthy weight, non-
smoking and a healthy diet (HR=0.62; 95% CI: 0.49 to
0.78) was associated with as lower risk as the combination
of five lifestyle factors (HR=0.63; 95% CI: 0.54 to 0.74).
For most combinations, HLI scores of four and five were
similarly protective. In stratified analyses, no substantial
differences in the results were seen according to the age
strata of less or more than 52.4 years (P-difference=0.49)
and by EPIC participating country [see Additional file 4:
Figure S1; P-difference=0.17]. Overall there have not
been major differences between participants with and
without missing data according to the main study charac-
teristics and exposure variables (data not shown). In sensi-
tivity analyses, in a multivariable-adjusted model including
age, sex and education, additional adjustment for family
history did not substantially alter the risk estimate for the
association between HLI and CRC: HR=0.88 (95%CI:
0.86 to 0.91); P-value <0.0001. The results were also not
markedly changed after excluding cases diagnosed with
CRC within the first two years of study follow-up; the
HR for one point increase on the index was 0.77 (95%
CI: 0.71 to 0.83).
In this large prospective cohort study over a median
follow-up time of 12 years, an index based on five poten-
tially modifiable healthy lifestyle factors including healthy
weight, physical activity, non-smoking, limited alcohol
consumption and a healthy diet was inversely associated
with CRC risk. The associations were stronger among
men compared to women, particularly for rectal can-
cer. If these associations were causal, 16% of the new
CRC cases (22% in men and 11% in women) would
have been prevented had all participants been following
all five healthy lifestyles. These findings provide sex and
cancer-site specific estimates of the public health burden
of combined lifestyle factors for incident CRC in these
European populations.
Given the high incidence and mortality rates [37], pre-
vention strategies for reducing CRC are highly desired.
In this context, there have been numerous studies ex-
ploring individual lifestyle factors with regard to CRC
risk [11,38-40]. However, studies on the combined effect
of lifestyle factors on CRC risk have been more sparse
[41-43]. In a study of 47,927 US men in the prospective
Health Professionals Follow-up Cohort, after adjusting
for age and family history of CRC comparing the risk
score for the combined six modifiable colon cancer risk
factors (obesity, physical inactivity, alcohol consumption,
early adulthood cigarette smoking, red meat consump-
tion and low intake of folic acid from supplements) at or
above the approximate 20th, 10th, or 5th percentiles
versus below, the PAR% increased from 39% to 48% and
55%, respectively [41]. In the Nurses’ Health Study among
83,767 US women, those who smoked, had a consist-
ently high relative weight, low physical activity level, con-
sumed red or processed meat on a daily basis, were never
screened, and consumed low daily amounts of folate had
almost a four-fold higher risk of colon cancer by the age
of 70 years [43]. Another two studies provided data for
European populations. A Danish Diet Cancer and Health
cohort study [42] among 55,487 men and women, repor-
ted 11% lower risk of CRC in people who adhered to five
healthy lifestyle recommendations, including high phy-
sical activity, low waist circumference, not smoking, low
alcohol intake and a healthy diet (dietary fibre, energy per-
centage from fat, red and processed meat, and fruits and
vegetables). However, the study included participants
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Figure 1 Multivariable-adjusted hazard ratios (95% confidence intervals) of colorectal cancer according to increasing number of
healthy lifestyle factors. Healthy lifestyle index (range 0 to 5 points) is calculated by summing the binary lifestyle factor variables (0, 1) including
overweight and obesity, physical activity, smoking, alcohol consumption and diet quality. Participants received 1 point if they had any of the following
behaviours: healthy weight, physically active, non-smokers or former smokers, limited alcohol consumption or healthy diet quality. The hazard ratios
are calculated after stratification by EPIC study centre and multivariable adjustment for age at study recruitment, sex and educational status (none,
primary school, technical/professional school/not specified). P-value for the linear trend was calculated using the Wald test treating the index as a
continuous variable. EPIC. European Prospective Investigation into Cancer and Nutrition.
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http://www.biomedcentral.com/1741-7015/12/168only from Denmark and, therefore, its results may not be
generalisable for other European populations. Using data
from the EPIC cohort [44], a one-point increment in an
index based on the 2007 WCRF/AICR recommendations
was associated with a risk reduction of 12% (95% CI: 9%
to 16%) for CRC. However, this index was based solely on
BMI to define body fatness, whereas waist circumference
as a measure of abdominal obesity has been suggested to
be a more specific indicator for elevated metabolic risk
[45]. In particular, visceral adipose tissue is physiologically
more active than subcutaneous adipose tissue and
generates hormones and cytokines with inflammatory,
metabolic and direct carcinogenic potential, which may
directly or indirectly promote cancer development. Sug-
gested putative mechanisms that may account for the link
between obesity and CRC risk include hyperinsulinaemia,
chronic low-grade inflammation, altered immune re-
sponse, oxidative stress, as well as disturbances in insulin-
like growth factors, adipokines and sex steroids. In
addition, evidence has shown that while BMI is associated
with CRC risk in men only, abdominal obesity (as deter-
mined by waist circumference) is similarly strongly associ-
ated with CRC cancer both in men and in women,
suggesting that it may reflect cancer risk in both sexes
Table 4 Hazard ratios (HRs) of colorectal cancer according to the Healthy Lifestyle Index (HLI)
a, the EPIC cohort
(1992 to 2010)
HLI Colon cancer Rectal cancer Colorectal cancer
Cases, number HR
b (95% CI) Cases, number HR
b (95% CI) Cases, number HR
b (95% CI)
All participants
0 or 1 216 1 (Reference) 133 1 (Reference) 349 1 (Reference)
2 526 0.85 (0.72 to 0.99) 326 0.90 (0.74 to 1.11) 852 0.87 (0.76 to 0.98)
3 816 0.78 (0.67 to 0.91) 459 0.80 (0.66 to 0.97) 1275 0.79 (0.70 to 0.89)
4 602 0.64 (0.54 to 0.75) 348 0.70 (0.57 to 0.85) 950 0.66 (0.58 to 0.75)
5 209 0.61 (0.50 to 0.74) 124 0.68 (0.53 to 0.88) 333 0.63 (0.54 to 0.74)
P-trend <0.0001 <0.0001 <0.0001
Per one point increase 0.87 (0.84 to 0.91) 0.90 (0.85 to 0.94) 0.88 (0.86 to 0.92)
P-value
c <0.0001 <0.0001 <0.0001
Men
0 or 1 135 1 (Reference) 94 1 (Reference) 229 1 (Reference)
2 266 0.80 (0.65 to 0.98) 196 0.87 (0.67 to 1.10) 462 0.83 (0.71 to 0.97)
3 330 0.70 (0.57 to 0.85) 236 0.75 (0.59 to 0.95) 566 0.72 (0.62 to 0.84)
4 215 0.59 (0.46 to 0.73) 160 0.66 (0.51 to 0.85) 375 0.62 (0.52 to 0.73)
5 83 0.61 (0.46 to 0.81) 42 0.47 (0.32 to 0.68) 125 0.56 (0.44 to 0.69)
P-trend <0.0001 <0.0001 <0.0001
Per one point increase 0.86 (0.82 to 0.91) 0.86 (0.80 to 0.91) 0.87 (0.83 to 0.90)
P-value
c <0.0001 <0.0001 <0.0001
Women
0 or 1 81 1 (Reference) 39 1 (Reference) 120 1 (Reference)
2 260 0.93 (0.73 to 1.20) 130 1.03 (0.72 to 1.48) 390 0.97 (0.78 to 1.18)
3 486 0.91 (0.71 to 1.14) 223 0.96 (0.68 to 1.36) 709 0.92 (0.76 to 1.12)
4 387 0.72 (0.56 to 0.92) 188 0.84 (0.59 to 1.19) 575 0.76 (0.62 to 0.93)
5 126 0.65 (0.48 to 0.86) 82 1.01 (0.68 to 1.49) 208 0.76 (0.60 to 0.95)
P-trend
c <0.0001 0.35 <0.0001
Per one point increase 0.88 (0.84 to 0.93) 0.97 (0.99 to 1.04) 0.91 (0.87 to 0.95)
P-value <0.0001 0.35 <0.0001
aHealthy lifestyle index (range 0 to 5 points) is calculated by summing the binary lifestyle factor variables (0,1) including overweight and obesity, physical activity,
smoking, alcohol consumption and diet quality. Participants received one point if they had any of the following behaviours: healthy weight, physically active,
non-smokers or former smokers, limited alcohol consumption or healthy diet quality.
bMultivariable model stratified by EPIC study centre and adjusted for age at
study recruitment, sex and educational status (none, primary school, technical/professional school/not specified).
cP-value for the linear trend was calculated using
the Wald test treating the index as a continuous variable. Note: P-interaction by sex: 0.40, for colon cancer; 0.008 for rectal cancer; 0.03 for colorectal cancer. P for
interaction is assessed using the likelihood ratio test by generating a cross-product term between HLI and sex in the multivariable model. CI, confidence interval;
EPIC, European Prospective Investigation into Cancer and Health; HR, hazard ratio.
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http://www.biomedcentral.com/1741-7015/12/168more adequately compared to BMI [18]. Indeed, in our
data when only BMI was used to define healthy weight,
the estimated HR of CRC was 0.93 (95% CI: 0.87 to 1.00),
whereas the respective risk estimate for using only waist
circumference was lower: HR=0.82 (95% CI: 0.78 to
0.87). Taking the above into consideration, in our study
we used both BMI and waist circumference to define
healthy weight. Furthermore, the WCRF /AICR score used
general dietary recommendations for cancer prevention,
whereas it may be important to consider foods that have
been specifically related to CRC risk. We designed an a-
priori based healthy diet quality index that comprised in-
dividual foods specifically shown to be associated to CRC
risk [2-8,11,12,38-40]. Using this index, we observed 37%
lower risk of CRC for people having all five healthy life-
style factors relative to those with none of these healthy
factors.
In the present study we observed a stronger associ-
ation between HLI and CRC among men than among
women. Similar findings have been reported also by the
Danish Diet Cancer and Health study [42], although the
number of cases was much lower in that study and the
Table 5 Population attributable risks (PARs) according to individual lifestyle factors and combined Healthy Lifestyle
Index (HLI)
a, the EPIC Cohort (1992 to 2010)
Colon cancer Rectal cancer Colorectal cancer
Cases, number
b %PAR (95% CI) Cases, number
b %PAR (95% CI) Cases, number
b %PAR (95% CI)
All participants
Individual lifestyle factors
c:
Overweight and obesity 1,231 10 (6 to 13) 671 3 (−1 to 7) 1,902 8 (5 to 11)
Physical activity 1,144 6 (2 to 10) 648 NA 1,792 3 (0 to 6)
Smoking 550 2 (−3 to 4) 378 4 (1 to 7) 928 4 (1 to 6)
Alcohol consumption 695 2 (−1 to 4) 462 6 (2 to 9) 1,157 4 (1 to 6)
Diet quality 1,084 5 (2 to 8) 629 5 (−2 to 9) 1,713 5 (2 to 7)
HLI <5
d 2,160 17 (6 to 26) 1,266 13 (−4 to 27) 3,426 16 (7 to 24)
Men
Individual lifestyle factors
c:
Overweight and obesity 602 15 (8 to 21) 393 5 (−2 to 11) 995 10 (5 to 14)
Physical activity 515 4 (−2t o9 ) 3 6 0 5( −7 to 15) 875 3 (−1t o6 )
Smoking 289 1 (−2 to 4) 223 3 (−2t o8 ) 5 1 2 4( −3 to 11)
Alcohol consumption 377 5 (1 to 9) 287 12 (5 to 18) 664 7 (3 to 10)
Diet quality 451 4 (−1 to 9) 342 12 (3 to 20) 793 6 (1 to 10)
HLI <5
d 946 13 (−8 to 28) 686 36 (13 to 53) 1,632 22 (7 to 34)
Women
Individual lifestyle factors
c:
Overweight and obesity 629 7 (2 to 11) 278 2 (−5t o8 ) 9 0 7 5( 1t o9 )
Physical activity 629 7 (1 to 12) 288 NA 917 2 (−2t o6 )
Smoking 261 11 (−27 to 37) 155 2 (−2 to 6) 416 1 (−1t o2 )
Alcohol consumption 318 NA 175 2 (−2 to 6) 493 1 (−3t o4 )
Diet quality 633 6 (1 to10) 287 NA 920 2 (0 to 4)
HLI <5
d 1,214 20 (6 to 32) 580 NA 1,794 11 (1 to 21)
aThe HLI (range 0 to 5 points) is calculated by summing the binary lifestyle factor variables (0,1) including overweight and obesity, physical activity, smoking,
alcohol consumption and diet quality. Participants received one point if they had any of the following behaviours: healthy weight, physically active, non-smokers
or former smokers, limited alcohol consumption or healthy diet quality.
bThe number of cases denotes those cases without the healthy lifestyle factor or not
adhering to all five healthy lifestyle factors.
cPAR according to each of the individual lifestyle factors, stratified by EPIC study centre, and adjusted for age, sex,
education (none, primary school, technical/professional school) and mutually adjusted for the other lifestyle factors, including overweight and obesity, physical
activity, smoking, alcohol consumption and diet quality (binary variables). PARs are calculated by reversing the coding of the protective factors and taking into
account the relative proportion of exposed cases based on the formula from Miettinen et al.[ 31]. The 95% CIs are calculated based on the formula of Whittemore
et al.[ 33]. The PARs denote the percentage of colorectal cancer cases in the population that are attributable to the non-adherence to the particular healthy
lifestyle factor.
dPAR, stratified by EPIC study centre, and adjusted for age at study recruitment, sex and educational status (none, primary school, technical/
professional school). The PAR denotes the percentage of colorectal cancer cases in the population that are attributable to the non-adherence to five healthy
lifestyle behaviours. PARs are calculated based on a formula from Bruzzi et al.[ 32]. The 95% CIs are calculated based on the formula of Whittemore et al.[ 33].
Note: No meaningful PAR estimates were obtained for the associations of : physical activity and rectal cancer in all participants; alcohol consumption and colon
cancer in women; as well as for physical activity and diet quality and rectal cancer in women, because the estimated hazard ratios for these individual factors in
women were close to 1 (Please, see Table 3). CI, confidence interval; EPIC, European Prospective Investigation into Cancer and Nutrition.
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http://www.biomedcentral.com/1741-7015/12/168interaction by sex was not statistically significant. In
addition, we also observed a cancer site and sex-specific
gradient in the PARs such that 36% of rectal cancer
cases in men and 20% of colon cancer cases in women
would have been prevented if all participants adhered to
all five healthy lifestyle factors, whereas no statistically
significant PARs were seen in men for colon cancer and
in women for rectal cancer. These suggested sex differ-
ences could be accounted for by differences in exposure
distribution among men and women, quality of reporting
lifestyle data or by biological differences among sexes. Our
data revealed that overweight and obesity statistically ex-
plained the association between HLI and colon cancer in
men but not in women. These data are in line with previ-
ous evidence on the role of obesity as a stronger risk fac-
tor for colon cancer in men compared to women [18].
Different biological mechanisms have been suggested to
explain the associations of obesity and colon cancer in
men and in women. Thus, our previous work has sug-
gested that inflammation and oxidative stress underlies
this association in men, whereas hyperinsulinaemia was
the candidate explaining the pathway in women [46].
More research is needed to shed light on potential bio-
logical pathways that may underlie these relations.
When interpreting PARs, it should be taken into ac-
count that these measures rely on the distribution of
lifestyle factors among participants in the present cohort
study. Furthermore, PARs assume that the exposures are
causal and unbiased, but studies with observational de-
sign are not sufficiently able to prove this assumption.
Nevertheless, this knowledge may still be useful for tai-
loring interventions for lifestyle modification at target
population subgroups.
As lifestyle patterns occur simultaneously and the mag-
nitude of the associations may vary according to each
individual’s present factors, we also examined the associa-
tions according to different combinations of factors. In
these analyses, we observed that a combination of three
factors, including healthy weight, non-smoking and a
healthy diet quality, was related to a lower CRC risk as
low as the five factors altogether, suggesting the relative
importance of this particular healthy lifestyle pattern for
CRC prevention. However, due to the low prevalence of
each specific combination of factors, more research is
needed to investigate diversity of lifestyle patterns in rela-
tion to CRC risk.
The strengths of the present study include the large
sample size, the prospective study design, and the long
follow-up time of the EPIC cohort. An important advan-
tage of the study is the availability of measured rather
than self-reported anthropometric information, as well
as detailed dietary and lifestyle information collected using
Healthy weight + High PA + Non-smoking + Limited alcohol + Healthy diet (10.9%)
High PA + Non-smoking + Limited alcohol + Healthy diet (9.1%)
Healthy weight + High PA + Non-smoking + Healthy diet (3.1%)
Healthy weight + High PA + Limited alcohol + Healthy diet (2.5 %)
Healthy weight + Non-smoking + Limited alcohol + Healthy diet (10.4%)
Healthy weight + High PA + Non-smoking + Limited alcohol (5.6%)
Non-smoking + Limited alcohol + Healthy diet (5.8%)
High PA + Limited alcohol + Healthy diet (1.7%)
High PA + Non-smoking + Healthy diet (2.4%)
High PA + Non-smoking + Limited alcohol (5.1%)
Healthy weight +  Limited alcohol + Healthy diet (2.1%)
Healthy weight + Non-smoking + Healthy diet (3.8%)
Healthy weight + Non-smoking + Limited alcohol (6.2%)
Healthy weight + High PA + Healthy diet (1.3%)
Healthy weight + High PA + Limited alcohol (2.2%)
Healthy weight + High PA + Non-smoking (1.9%)
Limited alcohol + Healthy diet (1.6%)
Non-smoking + Healthy diet (2.1%)
Non-smoking + Limited Alcohol (4.1%)
High PA + Healthy Diet (1.0%) 
High PA+ Limited alcohol (1.5%)
High PA + Non-smoking (1.5%)
Healthy weight + Healthy diet (1.3%)
Healthy weight + Limited alcohol (2.3%)
Healthy weight + Non-smoking (2.4%)
Healthy weight + High PA (1.2%)
0 or 1 factors [Reference] (9.3%)
0.0                             0.5                              1.0                              1.5                         2.0
Combination of factors    Prevalence (%)
Figure 2 Multivariable-adjusted hazard ratios of colorectal cancer according to combinations of healthy lifestyle factors. HRs are shown
for persons with the respective combination of healthy lifestyle factors compared with persons with none or one of the lifestyle factors; The
multivariable model is stratified by EPIC study centre and adjusted for age at study recruitment, sex and educational status (none, primary school,
technical/professional school/ not specified). The presented prevalences (%) represent the frequency distribution of the respective combinations
of healthy lifestyle factors among the total study population. Within the reference group of individuals with 0 or 1 healthy lifestyle factors, 0.8%
had 0 factors, 1.1% had only healthy weight; 0.85% had only high physical activity, 1.6% had only non-smoking, 1.4% had only limited alcohol
and 0.9% had only healthy diet. CI, confidence interval; EPIC, European Prospective Investigation into Cancer and Nutrition; HR, hazard ratio.
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http://www.biomedcentral.com/1741-7015/12/168standardised procedures and validated instruments. The
present study has several limitations. In order to construct
the HLI, we dichotomised each lifestyle factor according
to pre-defined cut-off points. Different threshold values
would have resulted in different risk estimates. The choice
of cut-off points was mostly based on public health
recommendations and was generalised rather than risk-
specific. Because the use of equal weights is an imperfect
approximation of the underlying biological relationships
between the different health behaviours and CRC, future
analyses should examine the potential influence of the dif-
ferent weightings. The dichotomisation of variables in-
cluded in the lifestyle index is associated with several
methodological challenges, including loss of information,
power and potential for underestimating the extent of
variation in risk. Discarding a high proportion of the data
is particularly problematic when studies are too small and,
hence, underpowered. However, EPIC is a large prospect-
ive study with a long follow-up time, therefore having suf-
ficient power to detect underlying relationships between
healthy lifestyle factors and CRC risk. Nevertheless, the
likely influence of the dichotomisation of the variables in
the index is underestimating the true effect of the ob-
served associations. We used multivariable models to ad-
just for additional confounders; however, the potential for
residual confounding remains. Measurement error in self-
reported variables cannot be ruled out; however, such
error would likely lead to a non-differential bias poten-
tially leading to underestimating the true effects. We used
a simplified diet quality index that may not sufficiently ac-
count for the complexity of diets. A large proportion of
participants were excluded because of missing information
on main exposure variables which may have potentially
biased the risk estimates if the participants with missing
data are not similar to those with complete data. In our
data overall there have not been major differences be-
tween participants with and without missing data ac-
cording to the main study characteristics and exposure
variables; therefore, it is unlikely that using the complete
data analysis approach would have influenced our find-
ings. Endoscopic examinations of the large bowel have
been associated with general health behaviour and lower
CRC risk and, therefore, may potentially confound the
association between lifestyle factors and CRC risk. Un-
fortunately, in the EPIC study no information on CRC
screening, that is, colonoscopy or sigmoidoscopy, has been
systematically collected and we were not able to account
for this factor in statistical analyses. However, previous
studies which controlled for colonoscopy screening did
not report a change in the association between healthy
lifestyle behaviours and CRC risk [47]. In addition, when
we stratified the analyses by age of 50 or 55 when most
screening programs in Europe are introduced, we did not
observe different results; therefore, it is unlikely that the
main study findings could have been largely influenced by
this factor. Finally, the combined HLI did not include all
possible lifestyles, that is, non-steroidal anti-inflammatory
drug use or dietary nutrients (calcium, vitamin D) that
could additionally influence CRC risk. If added to the
index, the estimated PARs could have been potentially
higher.
Conclusions
In conclusion, combined lifestyle factors - healthy weight,
high physical activity, non-smoking, limited alcohol con-
sumption and a healthy diet - are associated with a lower
CRC incidence in European populations characterized by
western lifestyles. These data support the notion that the
complex nature and multiple dimensions of health behav-
iours may be better captured in analyses of lifestyle factors
in combination compared to modeling individual factors
alone. From a prevention perspective, using combina-
tions of modifiable lifestyle factors in CRC risk assessment
promises to be a successful, yet simple, approach for
translation of epidemiologic findings into primary cancer
prevention.
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